How effective is Requip for Agitation? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 3.7/5
This is a phase IV clinical study of how effective Requip (ropinirole hydrochloride) is for Agitation and for what kind of people. The study is created by eHealthMe from 22 Requip users and is updated continuously.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
What is Agitation?
Agitation (state of anxiety or nervous excitement) is found to be associated with 2,283 drugs and 3,318 conditions by eHealthMe. Check the latest studies of Agitation.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
22 people are studied for taking Requip in Agitation
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Requip effectiveness for Agitation (number of people):
Overall:
- not at all: 2
- somewhat: 3
- moderate: 10
- high: 6
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 3
- high: 3
- very high: 1
Gender of people who take Requip for Agitation *:
- female: 95.45 %
- male: 4.55 %
Age of people who take Requip for Agitation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.09 %
- 40-49: 22.73 %
- 50-59: 31.82 %
- 60+: 36.36 %
Who find Requip more effective for Agitation?
Gender of people who take Requip for Agitation *:
- female: 100 %
- male: 0.0 %
Age of people who take Requip for Agitation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 28.57 %
- 50-59: 42.86 %
- 60+: 28.57 %
* Approximation only. Some reports may have incomplete information.
Do you take Requip?
- You can start a phase IV clinical trial to monitor Requip safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Requip (22,950 reports)
Treatments, associated drugs and conditions:
- Agitation (142,108 reports)
How the study uses the data?
The study is based on ropinirole hydrochloride (the active ingredients of Requip) and Requip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methocarbamol cause Metastases To Lymph Nodes? - 40 seconds ago
- Drug interactions of Unasyn and Lasix - 52 seconds ago
- Could Solifenacin Succinate cause Eye Pain? - 58 seconds ago
- Constipation in Amen, how severe and when it was recovered? - a minute ago
- Could Defitelio cause Bleeding Disorders? - a minute ago
- Could Diltiazem Hydrochloride cause Nausea And Vomiting? - a minute ago
- Could Plaquenil cause Abnormal Behavior? - a minute ago
- Vivitrol and Injection Site Abscess for Men aged 40-49 - 2 minutes ago
- Could Promethazine cause Neurogenic Bladder? - 2 minutes ago
- Drug interactions of Tramadol and Creatine Monohydrate - 2 minutes ago